Evidence map›Paper›PMID 26601915›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2016

Glutamate Receptor Interacting Protein 1 Regulates CD4(+) CTLA-4 Expression and Transplant Rejection.

K L Modjeski, S C Levy, S K Ture, D J Field, G Shi, K Ko, Q Zhu, C N Morrell

Open access · bronzeAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

K L ModjeskiAab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY.
S C LevyAab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY.
S K TureAab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY.
D J FieldAab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY.
G ShiAab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY.
K KoAab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY.
Q ZhuAab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY.
C N MorrellAab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY.
University of Rochester · US

Funding

The Role of Platelets in Alloantibody Mediated Transplant RejectionR01HL093179 · NHLBI · UNIVERSITY OF ROCHESTER · PI MORRELL, CRAIG N · 2008 to 2012
$2.2M
Novel platelet functions for in T-cell helper cell responsesR01HL124018 · NHLBI · UNIVERSITY OF ROCHESTER · PI MORRELL, CRAIG N · 2015 to 2018
$1.5M
NHLBI NIH HHS R01 HL093179NHLBI NIH HHS R01 HL124018
6 · The paper itself

Abstract

PDZ domains are common 80- to 90-amino-acid regions named after the first three proteins discovered to share these domains: postsynaptic density 95, discs large, and zonula occludens. PDZ domain-containing proteins typically interact with the C-terminus of membrane receptors. Glutamate receptor interacting protein 1 (GRIP1), a seven-PDZ domain protein scaffold, regulates glutamate receptor surface expression and trafficking in neurons. We have found that human and mouse T cells also express GRIP1. T cell-specific GRIP1(-/-) mice >11 weeks old had prolonged cardiac allograft survival. Compared with wild-type T cells, in vitro stimulated GRIP1(-/-) T cells had decreased expression of activation markers and increased apoptotic surface marker expression. Surface expression of the strong T cell inhibitory molecule cytotoxic T lymphocyte antigen-4 (CTLA-4) was increased on GRIP1(-/-) T cells from mice >11 weeks old. CTLA-4 increases with T cell stimulation and its surface expression on GRIP1(-/-) T cells remained high after stimulation was removed, indicating a possible internalization defect in GRIP1-deficient T cells. CTLA-4-blocking antibody treatment following heart transplantation led to complete rejection in T cell GRIP1(-/-) mice, indicating that increased CTLA-4 surface expression contributed to the extended graft survival. Our data indicate that GRIP1 regulates T cell activation by regulating CTLA-4 surface expression.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCD4-Positive T-LymphocytesCells, CulturedCTLA-4 AntigenGraft RejectionGraft SurvivalHeart TransplantationMaleMiceMice, Inbred C57BLMice, KnockoutNerve Tissue ProteinsAdaptor Proteins, Signal TransducingCTLA-4 AntigenGrip1 protein, mouseNerve Tissue Proteins

Identifiers

PMID26601915
PMCPMC5672809
OpenAlexW2176080846

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.